Startups
Biosceptre is developing targeted therapeutics and immune-oncology products against nfP2X7, a cancer target that has been shown to be present on the majority of cancers. Our goal is to bring novel antibody and CAR T therapeutics to patients suffering from a wide range of malignancies.
Overview
Location
United Kingdom, England, Cambridge
Employees
11-50
Total raised
$10.66M
Founded date
2010
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Biosceptre | “Biosceptre – Promise beyond cancer” |
Reviews 0
FAQ about Biosceptre International Limited
When was Biosceptre International Limited founded?
Biosceptre International Limited was founded in 2010.
How much funding has Biosceptre International Limited raised?
Biosceptre International Limited has raised $10.66M in total across 1 funding round.
What has the press written about Biosceptre International Limited?
Parsers VC has collected 2 articles mentioning Biosceptre International Limited, among them “Biosceptre”.
Is Biosceptre International Limited still active?
Yes, Biosceptre International Limited is active; its latest activity on Parsers VC dates from Dec 15, 2017.